Focal Therapeutics Release: Multiple Benefits Of Biozorb Surgical Marker Reported At BC3 Breast Cancer Conference
2/26/2014 9:39:37 AM
WASHINGTON--(BUSINESS WIRE)--The BioZorb™ three-dimensional surgical marker improved targeting for radiation therapy by enhancing visualization of the breast cancer lumpectomy cavity, according to a presentation at the 2014 Breast Cancer Coordinated Care (BC3) conference in Washington D.C.
Help employers find you! Check out all the jobs and post your resume.
comments powered by